ACROVIS biostructures - new technologies in drug discovery
ACROVIS is a biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of human and animal diseases for which current therapy is either lacking or ineffective. Our company has built up a fully integrated drug development platform that spans therapeutic target identification to drug development.
We also run a successful fee-for-service contract research business. We offer integrated services for protein structure-based drug discovery, combining in-depth expertise in chemoinformatics and structural biology with classical medicinal chemistry and organic synthesis. The following pages will introduce you to our company, as well as our technologies and current projects. Should you have any further queries, please do not hesitate to contact us. We will gladly assist you.